Dr Reddy's Laboratories gained 3.37% to Rs 2,006.95 at 13:25 IST on BSE after the company announced that the audit of its API plant at Andhra Pradesh has been completed.
The announcement was made on Saturday, 2 June 2018.Meanwhile, the S&P BSE Sensex was down 88.40 points, or 0.25% to 35,138.86.
On the BSE, 70,000 shares were traded in the counter so far compared with average daily volumes of 44,000 shares in the past two weeks. The stock had hit a high of Rs 2,024.05 and a low of Rs 1,964 so far during the day. The stock hit a 52-week high of Rs 2,788 on 24 July 2017. The stock hit a 52-week low of Rs 1,888 on 21 May 2018.
Dr Reddy's Laboratories announced that the audit of its API Srikakulam Plant (SEZ), Andhra Pradesh by the USFDA, has been completed with no observations.
Dr Reddy's Laboratories' consolidated net profit fell 19.4% to Rs 272.10 crore on 0.93% fall in total income to Rs 3598.80 crore in Q4 March 2018 over Q4 March 2017.
Dr Reddy's Laboratories is an integrated pharmaceutical company.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content